Delivering phage therapy per os: benefits and barriers.

about

Means to Facilitate the Overcoming of Gastric Juice Barrier by a Therapeutic Staphylococcal Bacteriophage A5/80.Phages of life - the path to pharma.

P2860

Q37716726-87249B64-4798-4044-853E-BEFD0A5C0138 Q47269772-9D225400-4358-434C-8810-6874CD9F4D20

P2860

Delivering phage therapy per os: benefits and barriers.

Item

http://www.wikidata.org/entity/Q39019401

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Delivering phage therapy per os: benefits and barriers.

@en

Delivering phage therapy per os: benefits and barriers.

@nl

type

Item

label

Delivering phage therapy per os: benefits and barriers.

@en

Delivering phage therapy per os: benefits and barriers.

@nl

prefLabel

Delivering phage therapy per os: benefits and barriers.

@en

Delivering phage therapy per os: benefits and barriers.

@nl

P1476

Delivering phage therapy per os: benefits and barriers.

@en

P2093

Krystyna Dabrowska

http://www.w3.org/2001/XMLSchema#string

Susan Zelasko

http://www.w3.org/2001/XMLSchema#string

P2860

Clostridium difficile phages: still difficult?

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

The incubation period of cholera: a systematic review

Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance

Experimental phage therapy against Staphylococcus aureus in mice

Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections

Global burden of invasive nontyphoidal Salmonella disease, 2010(1)

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

Exploiting host immunity: the Salmonella paradigm

Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections

P304

167-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14787210.2017.1265447

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrzej Górski

P577

2016-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27885865

http://www.w3.org/2001/XMLSchema#string

Delivering phage therapy per os: benefits and barriers.

about

P2860

P2860

Delivering phage therapy per os: benefits and barriers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698